Pomalidomide As an Immune-enhancing Agent for the Control of HIV

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This study is designed to evaluate the safety and efficacy of pomalidomide in HIV-1-infected individuals on ART and to determine the impact of pomalidomide on virological control in people living with HIV during an analytical treatment interruption.
Epistemonikos ID: 9fe6aee236befb134896c8188a61ba4f71cad1a0
First added on: Apr 17, 2025